BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)
| 4.25 Delayed Data As of Aug 04 |  -0.17 / -3.86%Today’s Change | 1.38 Today|||52-Week Range 6.29 | +23.04% Year-to-Date |
Latest BCRX News | Press Releases
No recent news for BioCryst Pharmaceuticals Inc.
Today’s Trading
| Previous close | 4.40 |
| Today’s open | 4.46 |
| Day’s range | 4.21 - 4.50 |
| Volume | 6,100,635 |
| Average volume (3 months) | 9,653,002 |
| Market cap | $707.0M |
Data as of 4:00pm ET, 08/04/2020
Growth & Valuation
| Earnings growth (last year) | +4.00% |
| Earnings growth (this year) | +4.61% |
| Earnings growth (next 5 years) | +19.86% |
| Revenue growth (last year) | +136.45% |
| P/E ratio | NM |
| Price/Sales | 8.17 |
| Price/Book | 16.45 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MORFMorphic Holding Inc | -0.60 | -2.54% |
| AUTLAutolus Therapeutics... | +0.72 | +5.15% |
| IMGNImmunoGen Inc | -0.19 | -4.68% |
| CODXCo-Diagnostics Inc | -2.42 | -7.86% |
Data as of 5:10pm ET, 08/04/2020
Financials
| Next reporting date | August 6, 2020 |
| EPS forecast (this quarter) | -$0.26 |
| Annual revenue (last year) | $48.8M |
| Annual profit (last year) | -$108.9M |
| Net profit margin | -222.99% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
